Dr Subotheni Thavaneswaran

Dr Subotheni Thavaneswaran (Subo) joined the CTC as a Senior Research Fellow in 2020. She serves as a clinical lead for the Molecular Screening and Therapeutics (MoST) Program. MoST is a pan-cancer program that aims to link comprehensive genomic profiling results to therapeutic opportunities for patients with advanced cancers. Subo previously worked at the CTC between 2015-2016 as a Research fellow for AGITG and ALTG. Since then, she has completed a Master of Medicine (Clinical Epidemiology) and was awarded her PhD, titled ‘The Clinical Translation of Genomic Output in Oncology’ at the Garvan Institute of Medical Research.

Subo is also a practising medical oncologist, having obtained her FRACP in 2015. She is a staff specialist at The Kinghorn Cancer Centre, St Vincent’s Public Hospital where her clinical expertise includes the management of colorectal and primary brain cancers.

Subo has also been the recipient of many awards including a UNSW Best Publication Award in 2019, an Australian Genomics and Health Alliance PhD Top-up Scholarship in 2017, an AGITG Best Fast Forward Presentation Award in 2017, and an Australian Postgraduate Award from UNSW in 2016. She was also one of two Garvan Institute nominees for the 2020 CSL Florey Next Generation Award.